Sivia Capital Partners’s Gilead Sciences GILD Stock Holding History

Sivia Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Hold	1,653	–	–	0.03%	518
2026 Q1	$230K	Sell	1,653 -2,638	-61%	-$369K	0.04%	402
2025 Q4	$527K	Sell	4,291 -19	-0.4%	-$2.31K	0.11%	256
2025 Q3	$478K	Buy	4,310 +128	+3%	+$14.5K	0.14%	184
2025 Q2	$464K	Buy	4,182 +602	+17%	+$64.1K	0.16%	143
2025 Q1	$401K	Buy	3,580 +262	+8%	+$27K	0.19%	108
2024 Q4	$306K	Buy	3,318 +69	+2%	+$6.21K	0.15%	111
2024 Q3	$272K	Buy	3,249 +123	+4%	+$9.38K	0.16%	133
2024 Q2	$214K	Buy	+3,126	New	+$209K	0.14%	162
2024 Q1	–	Sell	-3,122	Closed	-$253K	–	193
2023 Q4	$253K	Buy	+3,122	New	+$243K	0.19%	124

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Sivia Capital Partners's GILD Position: Q2 2026 in Review

Sivia Capital Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,653 shares worth $209K. The position accounts for 0.03% of the portfolio, ranked #518.

Sivia Capital Partners first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $527K in Q4 2025. 632 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Sivia Capital Partners held 1,653 shares of Gilead Sciences worth $209K as of Q2 2026.
Sivia Capital Partners left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.03% of Sivia Capital Partners's portfolio in Q2 2026, its #518 holding.
Sivia Capital Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
Sivia Capital Partners's Gilead Sciences position peaked at $527K in Q4 2025.
632 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.